Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - JP
$ 12.92
-0.996 %
$ 41 B
Market Cap
22.28
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
3.49%
EBIT
Estimate
21.26%
Net Income
Estimate
11.64%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Takeda Pharmaceutical Company Limited
TAK has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart TAK
EBIT FORECAST
EBIT Forecast Chart TAK
NET INCOME FORECAST
Net Income Chart TAK